A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor.

A phase 1 study of a new ribonucleotide reductase inhibitor, didox, was performed by administration of escalating doses of the drug by slow i.v. injection. Thirty-four patients with unresponsive metastatic carcinoma received the drug. There were 13 escalations of dosage, from a starting dose of 192...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Veale, D., Carmichael, J., Cantwell, B. M., Elford, H. L., Blackie, R., Kerr, D. J., Kaye, S. B., Harris, A. L.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 1988
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2246479/
https://ncbi.nlm.nih.gov/pubmed/3048353
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker